
Sign up to save your podcasts
Or


HERE’S THE PROBLEM. Federally funded cancer research has fueled nearly every major advancement in cancer care over the last 50 years and contributed to progress in other areas of medicine. Today, more than 18 million Americans are alive thanks to federally funded cancer research, screening, and prevention. If these cuts are implemented, it will be devastating to the pace and progress of cancer research in America.
Write Your Congress Person to Oppose these Budget Cuts. It's up to US.
https://bit.ly/asco-save-cancer-research
With us to talk about this today is Julie R. Gralow, MD, Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology (ASCO) who can discuss the role of federal research investment, what the proposed changes could mean for patients and providers, and how the scientific community may be affected.
Learn more here: https://bit.ly/cancer-research-cutbacks
If you're enjoying the Show, it would mean the world to us if you took a second to leave a five star review on YouTube, Apple Podcasts, or Spotify, or wherever you're listening to us. It helps more people find the show and lets us know we're on the right track. We thank you in advance
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Jonathan Marx, MBA5
33 ratings
HERE’S THE PROBLEM. Federally funded cancer research has fueled nearly every major advancement in cancer care over the last 50 years and contributed to progress in other areas of medicine. Today, more than 18 million Americans are alive thanks to federally funded cancer research, screening, and prevention. If these cuts are implemented, it will be devastating to the pace and progress of cancer research in America.
Write Your Congress Person to Oppose these Budget Cuts. It's up to US.
https://bit.ly/asco-save-cancer-research
With us to talk about this today is Julie R. Gralow, MD, Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology (ASCO) who can discuss the role of federal research investment, what the proposed changes could mean for patients and providers, and how the scientific community may be affected.
Learn more here: https://bit.ly/cancer-research-cutbacks
If you're enjoying the Show, it would mean the world to us if you took a second to leave a five star review on YouTube, Apple Podcasts, or Spotify, or wherever you're listening to us. It helps more people find the show and lets us know we're on the right track. We thank you in advance
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Learn more about your ad choices. Visit megaphone.fm/adchoices

190 Listeners

280 Listeners

97 Listeners

95 Listeners

112 Listeners

66 Listeners

15 Listeners

71 Listeners

29 Listeners

27 Listeners